FMR1 Gene Mutation Status (Activation/Inactivation Assessment)

What This Test Measures

The test examines the FMR1 gene, which produces the fragile X mental retardation protein (FMRP). Mutations in this gene can lead to reduced or absent protein production, contributing to Fragile X syndrome or other neurodevelopmental disorders. The test may involve analyzing DNA from a blood sample to detect specific mutations or changes in gene expression.

Why It Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms of Fragile X syndrome (e.g., learning difficulties, developmental delays, or behavioral challenges), a family history of the condition, or if you’re considering genetic counseling for reproductive planning.

Sample Collection and Preparation

A blood sample is typically drawn from a vein in your arm. The sample is sent to a lab for DNA analysis. If testing for gene expression (activation/inactivation), the lab may also check for methylation patterns or other molecular markers associated with FMR1 silencing.

What to Expect Before the Test

No special preparation is usually needed, but avoid alcohol or certain medications that could affect lab results. If you’re pregnant or have a history of bleeding disorders, inform your provider before the test.